DBlog Week: I Hate Paperwork and Phone Calls
Today is the first day of Diabetes Blog Week. Its founder, Karen Graffeo, proposes: “Let’s kick off Diabetes Blog Week by talking about the diabetes…
DBlog Week: Change the World!
It’s day one of the 5th annual Diabetes Blog week (organized by the amazing Karen Graffeo at Bittersweet Diabetes), and today’s topic…
Lilly Diabetes
Lilly’s New Basal Insulin Peglispro Proves Equal to Lantus in Phase 3 Clinical Trial
Eli Lilly and Company have announced positive top-line results of three completed Phase III clinical trials in patients with type 2 diabetes for basal insulin peglispro (BIL). Peglispro is being studied as a once-daily treatment for both type 1 and type 2 diabetes. The primary efficacy endpoint of non-inferior reduction in hemoglobin A1c (HbA1c) compared to insulin glargine was met in all three trials.
Recalling the Cure
I don’t know exactly when it happened. But a point came when I stopped regularly thinking about a cure for diabetes. It doesn’t cross my mind daily,…
macaroni and cheese, corn bread, and snap peas
Diabetes: An Emotional Rollercoaster
As I sit here at my desk, there are remnants of glucose tablet dust coating my fingers, tissues strewn about my desk, and used test strips littering…